eF-site ID 1r4n-ABCDEFGHIJKL
PDB Code 1r4n
Chain A, B, C, D, E, F, G, H, I, J, K, L
Title APPBP1-UBA3-NEDD8, an E1-ubiquitin-like protein complex with ATP
Classification CELL CYCLE
Compound amyloid beta precursor protein-binding protein 1
Source Homo sapiens (Human) (NEDD8_HUMAN)
Sequence A:  KLLKEQKYDRQLRLWGDHGQEALESAHVCLINATATGTEI
LKNLVLPGIGSFTIIDGNQVSGEDAGNNFFLQRSSIGKNR
AEAAMEFLQELNSDVSGSFVEESPENLLDNDPSFFCRFTV
VVATQLPESTSLRLADVLWNSQIPLLICRTYGLVGYMRII
IKEHPVIESHPDNALEDLRLDKPFPELREHFQSYDHSHTP
WIVIIAKYLAQWYSETNGRIPKTYKEKEDFRDLIRQGILK
PEDEENFEEAIKNVNTALNTTQIPSSIEDIFNDDRCINIT
KQTPSFWILARALKEFVAKEGQGNLPVRGTIPDMIADSGK
YIKLQNVYREKAKKDAAAVGNHVAKLLQSIGQAPESISEK
ELKLLCSNSAFLRVVRCRSLAEEYGLDTINKDEIISSMDN
PDNEIVLYLMLRAVDRFHKQQGRYPGVSNYQVEEDIGKLK
SCLTGFLQEYGLSVMVKDDYVHEFCRYGAAEPHTIAAFLG
GAAAQEVIKIITKQFVIFNNTYIYSGMSQTSATFQL
B:  DWEGRWNHVKKFLERSGPFTHPDFEPSTESLQFLLDTCKV
LVIGAGGLGCELLKNLALSGFRQIHVIDMDTIDVSNLNRQ
FLFRPKDIGRPKAEVAAEFLNDRVPNCNVVPHFNKIQDFN
DTFYRQFHIIVCGLDSIIARRWINGMLISLLNYEDGVLDP
SSIVPLIDGGTEGFKGNARVILPGMTACIECTLELYPPQV
NFPMATIASMPRLPEHCIEYVRMLQWPKEQPFGEGVPLDG
DDPEHIQWIFQKSLERASQYNIRGVTYRLTQGVVKRIIPA
VASTNAVIAAVCATEVFKIATSAYIPLNNYLVFNDVDGLY
TYTFEAERKENCPACSQLPQNIQFSPSAKLQEVLDYLTNS
ASLQMKSPAITATNRTLYLQSVTSIEERTRKELGLVDGQE
AVADVTTPQTVLFKLHFT
C:  KLLKEQKYDRQLRLWGDHGQEALESAHVCLINATATGTEI
LKNLVLPGIGSFTIIDGNQVSGEDAGNNFFLQRSSIGKNR
AEAAMEFLQELNSDVSGSFVEESPENLLDNDPSFFCRFTV
VVATQLPESTSLRLADVLWNSQIPLLICRTYGLVGYMRII
IKEHPVIESHPDNALEDLRLDKPFPELREHFQSYDHSHTP
WIVIIAKYLAQWYSETNGRIPKTYKEKEDFRDLIRQGILK
PEDEENFEEAIKNVNTALNTTQIPSSIEDIFNDDRCINIT
KQTPSFWILARALKEFVAKEGQGNLPVRGTIPDMIADSGK
YIKLQNVYREKAKKDAAAVGNHVAKLLQSIGQAPESISEK
ELKLLCSNSAFLRVVRCRSLAEEYGLDTINKDEIISSMDN
PDNEIVLYLMLRAVDRFHKQQGRYPGVSNYQVEEDIGKLK
SCLTGFLQEYGLSVMVKDDYVHEFCRYGAAEPHTIAAFLG
GAAAQEVIKIITKQFVIFNNTYIYSGMSQTSATFQL
D:  DWEGRWNHVKKFLERSGPFTHPDFEPSTESLQFLLDTCKV
LVIGAGGLGCELLKNLALSGFRQIHVIDMDTIDVSNLNRQ
FLFRPKDIGRPKAEVAAEFLNDRVPNCNVVPHFNKIQDFN
DTFYRQFHIIVCGLDSIIARRWINGMLISLLNYEDGVLDP
SSIVPLIDGGTEGFKGNARVILPGMTACIECTLELYPPQV
NFPMATIASMPRLPEHCIEYVRMLQWPKEQPFGEGVPLDG
DDPEHIQWIFQKSLERASQYNIRGVTYRLTQGVVKRIIPA
VASTNAVIAAVCATEVFKIATSAYIPLNNYLVFNDVDGLY
TYTFEAERKENCPACSQLPQNIQFSPSAKLQEVLDYLTNS
ASLQMKSPAITATNRTLYLQSVTSIEERTRKELGLVDGQE
AVADVTTPQTVLFKLHFT
E:  KLLKEQKYDRQLRLWGDHGQEALESAHVCLINATATGTEI
LKNLVLPGIGSFTIIDGNQVSGEDAGNNFFLQRSSIGKNR
AEAAMEFLQELNSDVSGSFVEESPENLLDNDPSFFCRFTV
VVATQLPESTSLRLADVLWNSQIPLLICRTYGLVGYMRII
IKEHPVIESHPDNALEDLRLDKPFPELREHFQSYDHSHTP
WIVIIAKYLAQWYSETNGRIPKTYKEKEDFRDLIRQGILK
PEDEENFEEAIKNVNTALNTTQIPSSIEDIFNDDRCINIT
KQTPSFWILARALKEFVAKEGQGNLPVRGTIPDMIADSGK
YIKLQNVYREKAKKDAAAVGNHVAKLLQSIGQAPESISEK
ELKLLCSNSAFLRVVRCRSLAEEYGLDTINKDEIISSMDN
PDNEIVLYLMLRAVDRFHKQQGRYPGVSNYQVEEDIGKLK
SCLTGFLQEYGLSVMVKDDYVHEFCRYGAAEPHTIAAFLG
GAAAQEVIKIITKQFVIFNNTYIYSGMSQTSATFQL
F:  DWEGRWNHVKKFLERSGPFTHPDFEPSTESLQFLLDTCKV
LVIGAGGLGCELLKNLALSGFRQIHVIDMDTIDVSNLNRQ
FLFRPKDIGRPKAEVAAEFLNDRVPNCNVVPHFNKIQDFN
DTFYRQFHIIVCGLDSIIARRWINGMLISLLNYEDGVLDP
SSIVPLIDGGTEGFKGNARVILPGMTACIECTLELYPPQV
NFPMATIASMPRLPEHCIEYVRMLQWPKEQPFGEGVPLDG
DDPEHIQWIFQKSLERASQYNIRGVTYRLTQGVVKRIIPA
VASTNAVIAAVCATEVFKIATSAYIPLNNYLVFNDVDGLY
TYTFEAERKENCPACSQLPQNIQFSPSAKLQEVLDYLTNS
ASLQMKSPAITATNRTLYLQSVTSIEERTRKELGLVDGQE
AVADVTTPQTVLFKLHFT
G:  KLLKEQKYDRQLRLWGDHGQEALESAHVCLINATATGTEI
LKNLVLPGIGSFTIIDGNQVSGEDAGNNFFLQRSSIGKNR
AEAAMEFLQELNSDVSGSFVEESPENLLDNDPSFFCRFTV
VVATQLPESTSLRLADVLWNSQIPLLICRTYGLVGYMRII
IKEHPVIESHPDNALEDLRLDKPFPELREHFQSYDHSHTP
WIVIIAKYLAQWYSETNGRIPKTYKEKEDFRDLIRQGILK
PEDEENFEEAIKNVNTALNTTQIPSSIEDIFNDDRCINIT
KQTPSFWILARALKEFVAKEGQGNLPVRGTIPDMIADSGK
YIKLQNVYREKAKKDAAAVGNHVAKLLQSIGQAPESISEK
ELKLLCSNSAFLRVVRCRSLAEEYGLDTINKDEIISSMDN
PDNEIVLYLMLRAVDRFHKQQGRYPGVSNYQVEEDIGKLK
SCLTGFLQEYGLSVMVKDDYVHEFCRYGAAEPHTIAAFLG
GAAAQEVIKIITKQFVIFNNTYIYSGMSQTSATFQL
H:  DWEGRWNHVKKFLERSGPFTHPDFEPSTESLQFLLDTCKV
LVIGAGGLGCELLKNLALSGFRQIHVIDMDTIDVSNLNRQ
FLFRPKDIGRPKAEVAAEFLNDRVPNCNVVPHFNKIQDFN
DTFYRQFHIIVCGLDSIIARRWINGMLISLLNYEDGVLDP
SSIVPLIDGGTEGFKGNARVILPGMTACIECTLELYPPQV
NFPMATIASMPRLPEHCIEYVRMLQWPKEQPFGEGVPLDG
DDPEHIQWIFQKSLERASQYNIRGVTYRLTQGVVKRIIPA
VASTNAVIAAVCATEVFKIATSAYIPLNNYLVFNDVDGLY
TYTFEAERKENCPACSQLPQNIQFSPSAKLQEVLDYLTNS
ASLQMKSPAITATNRTLYLQSVTSIEERTRKELGLVDGQE
AVADVTTPQTVLFKLHFT
I:  MLIKVKTLTGKEIEIDIEPTDKVERIKERVEEKEGIPPQQ
QRLIYSGKQMNDEKTAADYKILGGSVLHLVLALRGG
J:  MLIKVKTLTGKEIEIDIEPTDKVERIKERVEEKEGIPPQQ
QRLIYSGKQMNDEKTAADYKILGGSVLHLVLALRGG
K:  MLIKVKTLTGKEIEIDIEPTDKVERIKERVEEKEGIPPQQ
QRLIYSGKQMNDEKTAADYKILGGSVLHLVLALRGG
L:  MLIKVKTLTGKEIEIDIEPTDKVERIKERVEEKEGIPPQQ
QRLIYSGKQMNDEKTAADYKILGGSVLHLVLALRGG
Description


Functional site

1) chain H
residue 199
type
sequence C
description BINDING SITE FOR RESIDUE ZN H 1
source : AC1

2) chain H
residue 202
type
sequence C
description BINDING SITE FOR RESIDUE ZN H 1
source : AC1

3) chain H
residue 343
type
sequence C
description BINDING SITE FOR RESIDUE ZN H 1
source : AC1

4) chain H
residue 346
type
sequence C
description BINDING SITE FOR RESIDUE ZN H 1
source : AC1

5) chain D
residue 338
type
sequence E
description BINDING SITE FOR RESIDUE ZN J 2
source : AC2

6) chain J
residue 148
type
sequence K
description BINDING SITE FOR RESIDUE ZN J 2
source : AC2

7) chain F
residue 199
type
sequence C
description BINDING SITE FOR RESIDUE ZN F 3
source : AC3

8) chain F
residue 202
type
sequence C
description BINDING SITE FOR RESIDUE ZN F 3
source : AC3

9) chain F
residue 343
type
sequence C
description BINDING SITE FOR RESIDUE ZN F 3
source : AC3

10) chain F
residue 346
type
sequence C
description BINDING SITE FOR RESIDUE ZN F 3
source : AC3

11) chain H
residue 340
type
sequence K
description BINDING SITE FOR RESIDUE ZN H 4
source : AC4

12) chain H
residue 373
type
sequence S
description BINDING SITE FOR RESIDUE ZN H 4
source : AC4

13) chain A
residue 15
type
sequence R
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

14) chain B
residue 56
type
sequence A
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

15) chain B
residue 57
type
sequence G
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

16) chain B
residue 79
type
sequence D
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

17) chain B
residue 80
type
sequence M
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

18) chain B
residue 81
type
sequence D
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

19) chain B
residue 90
type
sequence R
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

20) chain B
residue 91
type
sequence Q
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

21) chain B
residue 103
type
sequence K
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

22) chain B
residue 126
type
sequence K
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

23) chain B
residue 127
type
sequence I
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

24) chain B
residue 145
type
sequence L
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

25) chain B
residue 146
type
sequence D
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

26) chain B
residue 150
type
sequence A
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

27) chain I
residue 176
type
sequence G
description BINDING SITE FOR RESIDUE ATP B 5
source : AC5

28) chain C
residue 15
type
sequence R
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

29) chain D
residue 56
type
sequence A
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

30) chain D
residue 57
type
sequence G
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

31) chain D
residue 79
type
sequence D
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

32) chain D
residue 80
type
sequence M
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

33) chain D
residue 81
type
sequence D
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

34) chain D
residue 90
type
sequence R
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

35) chain D
residue 91
type
sequence Q
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

36) chain D
residue 103
type
sequence K
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

37) chain D
residue 125
type
sequence N
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

38) chain D
residue 126
type
sequence K
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

39) chain D
residue 127
type
sequence I
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

40) chain D
residue 128
type
sequence Q
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

41) chain D
residue 145
type
sequence L
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

42) chain D
residue 146
type
sequence D
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

43) chain J
residue 176
type
sequence G
description BINDING SITE FOR RESIDUE ATP D 6
source : AC6

44) chain E
residue 15
type
sequence R
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

45) chain F
residue 56
type
sequence A
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

46) chain F
residue 57
type
sequence G
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

47) chain F
residue 79
type
sequence D
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

48) chain F
residue 80
type
sequence M
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

49) chain F
residue 81
type
sequence D
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

50) chain F
residue 87
type
sequence N
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

51) chain F
residue 90
type
sequence R
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

52) chain F
residue 91
type
sequence Q
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

53) chain F
residue 103
type
sequence K
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

54) chain F
residue 125
type
sequence N
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

55) chain F
residue 126
type
sequence K
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

56) chain F
residue 127
type
sequence I
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

57) chain F
residue 128
type
sequence Q
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

58) chain F
residue 145
type
sequence L
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

59) chain F
residue 146
type
sequence D
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

60) chain K
residue 176
type
sequence G
description BINDING SITE FOR RESIDUE ATP F 7
source : AC7

61) chain G
residue 15
type
sequence R
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

62) chain H
residue 57
type
sequence G
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

63) chain H
residue 79
type
sequence D
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

64) chain H
residue 80
type
sequence M
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

65) chain H
residue 81
type
sequence D
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

66) chain H
residue 87
type
sequence N
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

67) chain H
residue 90
type
sequence R
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

68) chain H
residue 91
type
sequence Q
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

69) chain H
residue 103
type
sequence K
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

70) chain H
residue 125
type
sequence N
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

71) chain H
residue 126
type
sequence K
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

72) chain H
residue 127
type
sequence I
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

73) chain H
residue 128
type
sequence Q
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

74) chain H
residue 145
type
sequence L
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

75) chain H
residue 146
type
sequence D
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

76) chain L
residue 176
type
sequence G
description BINDING SITE FOR RESIDUE ATP H 8
source : AC8

77) chain I
residue 108
type SITE
sequence L
description Interaction with UBE1C => ECO:0000269|PubMed:14690597
source Swiss-Prot : SWS_FT_FI1

78) chain I
residue 144
type SITE
sequence I
description Interaction with UBE1C => ECO:0000269|PubMed:14690597
source Swiss-Prot : SWS_FT_FI1

79) chain J
residue 108
type SITE
sequence L
description Interaction with UBE1C => ECO:0000269|PubMed:14690597
source Swiss-Prot : SWS_FT_FI1

80) chain J
residue 144
type SITE
sequence I
description Interaction with UBE1C => ECO:0000269|PubMed:14690597
source Swiss-Prot : SWS_FT_FI1

81) chain K
residue 108
type SITE
sequence L
description Interaction with UBE1C => ECO:0000269|PubMed:14690597
source Swiss-Prot : SWS_FT_FI1

82) chain K
residue 144
type SITE
sequence I
description Interaction with UBE1C => ECO:0000269|PubMed:14690597
source Swiss-Prot : SWS_FT_FI1

83) chain L
residue 108
type SITE
sequence L
description Interaction with UBE1C => ECO:0000269|PubMed:14690597
source Swiss-Prot : SWS_FT_FI1

84) chain L
residue 144
type SITE
sequence I
description Interaction with UBE1C => ECO:0000269|PubMed:14690597
source Swiss-Prot : SWS_FT_FI1

85) chain I
residue 140
type MOD_RES
sequence Q
description (Microbial infection) Deamidated glutamine => ECO:0000269|PubMed:20688984, ECO:0000269|PubMed:21903097, ECO:0000269|PubMed:23175788, ECO:0000269|PubMed:23589306, ECO:0000269|PubMed:26632597
source Swiss-Prot : SWS_FT_FI2

86) chain J
residue 140
type MOD_RES
sequence Q
description (Microbial infection) Deamidated glutamine => ECO:0000269|PubMed:20688984, ECO:0000269|PubMed:21903097, ECO:0000269|PubMed:23175788, ECO:0000269|PubMed:23589306, ECO:0000269|PubMed:26632597
source Swiss-Prot : SWS_FT_FI2

87) chain K
residue 140
type MOD_RES
sequence Q
description (Microbial infection) Deamidated glutamine => ECO:0000269|PubMed:20688984, ECO:0000269|PubMed:21903097, ECO:0000269|PubMed:23175788, ECO:0000269|PubMed:23589306, ECO:0000269|PubMed:26632597
source Swiss-Prot : SWS_FT_FI2

88) chain L
residue 140
type MOD_RES
sequence Q
description (Microbial infection) Deamidated glutamine => ECO:0000269|PubMed:20688984, ECO:0000269|PubMed:21903097, ECO:0000269|PubMed:23175788, ECO:0000269|PubMed:23589306, ECO:0000269|PubMed:26632597
source Swiss-Prot : SWS_FT_FI2

89) chain F
residue 79
type MOD_RES
sequence D
description (Microbial infection) Deamidated glutamine => ECO:0000269|PubMed:20688984, ECO:0000269|PubMed:21903097, ECO:0000269|PubMed:23175788, ECO:0000269|PubMed:23589306, ECO:0000269|PubMed:26632597
source Swiss-Prot : SWS_FT_FI2

90) chain F
residue 127
type MOD_RES
sequence I
description (Microbial infection) Deamidated glutamine => ECO:0000269|PubMed:20688984, ECO:0000269|PubMed:21903097, ECO:0000269|PubMed:23175788, ECO:0000269|PubMed:23589306, ECO:0000269|PubMed:26632597
source Swiss-Prot : SWS_FT_FI2

91) chain H
residue 79
type MOD_RES
sequence D
description (Microbial infection) Deamidated glutamine => ECO:0000269|PubMed:20688984, ECO:0000269|PubMed:21903097, ECO:0000269|PubMed:23175788, ECO:0000269|PubMed:23589306, ECO:0000269|PubMed:26632597
source Swiss-Prot : SWS_FT_FI2

92) chain H
residue 127
type MOD_RES
sequence I
description (Microbial infection) Deamidated glutamine => ECO:0000269|PubMed:20688984, ECO:0000269|PubMed:21903097, ECO:0000269|PubMed:23175788, ECO:0000269|PubMed:23589306, ECO:0000269|PubMed:26632597
source Swiss-Prot : SWS_FT_FI2

93) chain I
residue 148
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:P29595
source Swiss-Prot : SWS_FT_FI3

94) chain J
residue 148
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:P29595
source Swiss-Prot : SWS_FT_FI3

95) chain K
residue 148
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:P29595
source Swiss-Prot : SWS_FT_FI3

96) chain L
residue 148
type MOD_RES
sequence K
description N6-acetyllysine => ECO:0000250|UniProtKB:P29595
source Swiss-Prot : SWS_FT_FI3

97) chain I
residue 176
type CROSSLNK
sequence G
description Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
source Swiss-Prot : SWS_FT_FI4

98) chain C
residue 346
type CROSSLNK
sequence Y
description Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
source Swiss-Prot : SWS_FT_FI4

99) chain J
residue 176
type CROSSLNK
sequence G
description Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
source Swiss-Prot : SWS_FT_FI4

100) chain G
residue 346
type CROSSLNK
sequence Y
description Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
source Swiss-Prot : SWS_FT_FI4

101) chain K
residue 176
type CROSSLNK
sequence G
description Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
source Swiss-Prot : SWS_FT_FI4

102) chain L
residue 176
type CROSSLNK
sequence G
description Glycyl lysine isopeptide (Gly-Lys) (interchain with K-? in acceptor proteins)
source Swiss-Prot : SWS_FT_FI4

103) chain I
residue 127-152
type prosite
sequence KERVEEKEGIPPQQQRLIYSGKQMND
description UBIQUITIN_1 Ubiquitin domain signature. KerVeEkegIPpqqQrLIYsGkqmnD
source prosite : PS00299


Display surface

Download
Links